Cargando…

Impaired frequencies and function of platelets and tissue remodeling in chronic Chagas disease

Chronic inflammation, as a consequence of the persistent infection with Trypanosoma cruzi, leads to continuous activation of the immune system in patients with chronic Chagas disease. We have previously shown that increased sera levels of soluble P-selectin are associated with the severity of the ca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pengue, Claudia, Cesar, Gonzalo, Alvarez, María Gabriela, Bertocchi, Graciela, Lococo, Bruno, Viotti, Rodolfo, Natale, María Ailén, Castro Eiro, Melisa D., Cambiazzo, Silvia S., Perroni, Nancy, Nuñez, Myriam, Albareda, María Cecilia, Laucella, Susana A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6570032/ https://www.ncbi.nlm.nih.gov/pubmed/31199841 http://dx.doi.org/10.1371/journal.pone.0218260

Ejemplares similares

Distinct monocyte subset phenotypes in patients with different clinical forms of chronic Chagas disease and seronegative dilated cardiomyopathy
por: Pérez-Mazliah, Damián E., et al.
Publicado: (2018)

Correction: Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis
por: Natale, María A., et al.
Publicado: (2019)

Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis
por: Natale, María A., et al.
Publicado: (2018)

Immune exhaustion in chronic Chagas disease: Pro-inflammatory and immunomodulatory action of IL-27 in vitro
por: Natale, María Ailén, et al.
Publicado: (2021)

The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects
por: Castro Eiro, Melisa D., et al.
Publicado: (2017)

Mixed T Helper1/T Helper2/T Cytotoxic Profile in Subjects with Chronic Chagas Disease with Hypersensitivity Reactions to Benznidazole
por: Castro Eiro, Melisa D., et al.
Publicado: (2022)

Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses
por: Alvarez, María G., et al.
Publicado: (2016)

Impact of Aetiological Treatment on Conventional and Multiplex Serology in Chronic Chagas Disease
por: Viotti, Rodolfo, et al.
Publicado: (2011)

Allopurinol reduces antigen-specific and polyclonal activation of human T cells
por: Pérez-Mazliah, Damián, et al.
Publicado: (2012)

Modulation of Trypanosoma cruzi-specific T-cell responses after chemotherapy for chronic Chagas disease
por: Albareda, María Cecilia, et al.
Publicado: (2015)

Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes
por: Albareda, María C., et al.
Publicado: (2018)

Role of the Complement System in the Modulation of T-Cell Responses in Chronic Chagas Disease
por: Caputo, María Belén, et al.
Publicado: (2022)

Inhibitory Receptors Are Expressed by Trypanosoma cruzi-Specific Effector T Cells and in Hearts of Subjects with Chronic Chagas Disease
por: Argüello, Rafael J., et al.
Publicado: (2012)

Presence of Antigen-Experienced T Cells with Low Grade of Differentiation and Proliferative Potential in Chronic Chagas Disease Myocarditis
por: Argüello, Rafael J., et al.
Publicado: (2014)

Polyfunctional T Cell Responses in Children in Early Stages of Chronic Trypanosoma cruzi Infection Contrast with Monofunctional Responses of Long-term Infected Adults
por: Albareda, María C., et al.
Publicado: (2013)

HLA Class I-T Cell Epitopes from trans-Sialidase Proteins Reveal Functionally Distinct Subsets of CD8(+) T Cells in Chronic Chagas Disease
por: Alvarez, María G., et al.
Publicado: (2008)

Chagas Disease and the London Declaration on Neglected Tropical Diseases
por: Tarleton, Rick L., et al.
Publicado: (2014)

The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy
por: de Souza Pimentel, Walace, et al.
Publicado: (2012)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

Air Pollution’s Impact on Cardiac Remodeling in an Experimental Model of Chagas Cardiomyopathy
por: Fonseca, Keila Cardoso Barbosa, et al.
Publicado: (2022)

Molecular Remodeling of Cardiac Sinus Node Associated with Acute Chagas Disease Myocarditis
por: Rodríguez-Angulo, Héctor O., et al.
Publicado: (2021)

Obstructive Sleep Apnea is Common and Associated with Heart Remodeling in Patients with Chagas Disease
por: Medeiros, Carolina de Araújo, et al.
Publicado: (2018)

Trypanosoma cruzi Secreted Cyclophilin TcCyP19 as an Early Marker for Trypanocidal Treatment Efficiency
por: Perrone, Alina E., et al.
Publicado: (2023)

Reinfestation Sources for Chagas Disease Vector, Triatoma infestans, Argentina
por: Cecere, María C., et al.
Publicado: (2006)

Treatment of Chagas Cardiomyopathy
por: Botoni, Fernando A., et al.
Publicado: (2013)

Circulating miRNAs as Potential Biomarkers Associated with Cardiac Remodeling and Fibrosis in Chagas Disease Cardiomyopathy
por: Nonaka, Carolina Kymie Vasques, et al.
Publicado: (2019)

HIV and Chagas Disease Coinfection, a Tractable Disease?
por: Guidetto, Betiana, et al.
Publicado: (2019)

Extracellular Vesicles in Trypanosoma cruzi Infection: Immunomodulatory Effects and Future Perspectives as Potential Control Tools against Chagas Disease
por: Cortes-Serra, Nuria, et al.
Publicado: (2022)

Obstructive Sleep Apnea: A Marker of Cardiac Remodeling in Patients with Chronic Chagas Disease
por: Bestetti, Reinaldo B.
Publicado: (2018)

Cardiac Chagas Disease: MMPs, TIMPs, Galectins, and TGF-β as Tissue Remodelling Players
por: da Costa, Arthur Wilson Florencio, et al.
Publicado: (2019)

Chagas' Disease: Pregnancy and Congenital Transmission
por: Cevallos, Ana María, et al.
Publicado: (2014)

Does left ventricular reverse remodeling influence long-term outcomes in patients with Chagas cardiomyopathy?
por: Nakazone, Marcelo Arruda, et al.
Publicado: (2022)

Chagas prevention and control in an endemic area from the Argentinian Gran Chaco Region: Data from 14 years of uninterrupted intervention
por: Weinberg, Diego, et al.
Publicado: (2023)

Evaluation of the Chagas VirClia(®) and Chagas TESA VirClia(®) for the Diagnosis of Trypanosoma cruzi Infection
por: García-Bermejo, Isabel, et al.
Publicado: (2022)

Cardiac-Oxidized Antigens Are Targets of Immune Recognition by Antibodies and Potential Molecular Determinants in Chagas Disease Pathogenesis
por: Dhiman, Monisha, et al.
Publicado: (2012)

Chagas disease: national survey of seroprevalence in children under five years of age conducted in 2008
por: Russomando, Graciela, et al.
Publicado: (2017)

How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day
por: de Oliveira, Wilson Alves, et al.
Publicado: (2022)

T Cell Specificity: A Great Challenge in Chagas Disease
por: Ferragut, Fátima, et al.
Publicado: (2021)

Chagas disease vector control and Taylor's law
por: Cohen, Joel E., et al.
Publicado: (2017)

Lower urinary tract dysfunction in chronic Chagas disease: clinical and urodynamic presentation
por: Bey, Elsa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_91gd1sga1dasuant8pr7k18b0v